0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Phenylketonuria Therapeutic Market Research Report 2023
Published Date: September 2023
|
Report Code: QYRE-Auto-37D14028
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Phenylketonuria Therapeutic Market Research Report 2023
BUY CHAPTERS

Global Phenylketonuria Therapeutic Market Research Report 2023

Code: QYRE-Auto-37D14028
Report
September 2023
Pages:80
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Phenylketonuria Therapeutic Market Size

According to new survey, global Phenylketonuria Therapeutic market is projected to reach US$ 1783.2 million in 2029, increasing from US$ 1000 million in 2022, with the CAGR of 8.6% during the period of 2023 to 2029.

Phenylketonuria Therapeutic Market

Phenylketonuria Therapeutic Market

Phenylketonuria (PKU) is an inborn error of metabolism that results in decreased metabolism of the amino acid phenylalanine. Untreated PKU can lead to intellectual disability, seizures, behavioral problems, and mental disorder. It may also result in a musty smell and lighter skin. Babies born to mothers who have poorly treated PKU may have heart problems, a small head, and low birth weight.
Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Phenylketonuria Therapeutic market research.
The phenylketonuria (PKU) therapeutic market is primarily driven by the increasing prevalence of PKU and the growing demand for effective treatments to manage this rare genetic disorder. PKU is characterized by the inability to metabolize the amino acid phenylalanine, leading to its accumulation in the body, which can cause severe neurological and cognitive impairments if left untreated. As awareness about PKU and newborn screening programs improve, more patients are being diagnosed early, increasing the need for therapeutic interventions. However, the market also faces challenges, including the complexity of managing PKU through dietary restrictions and adherence to low-phenylalanine diets. This can be particularly challenging for young children and adults, impacting their quality of life and nutritional intake. Moreover, the limited availability of novel and more effective treatments for PKU poses a hurdle in addressing the unmet medical needs of patients. Addressing these challenges requires continued research and development of innovative therapies, including enzyme replacement therapies, gene therapies, and pharmacological interventions, to improve PKU management and alleviate dietary burdens. Additionally, raising awareness about PKU and its consequences among healthcare professionals and the general public is essential to facilitate early diagnosis and access to appropriate therapeutic options, ultimately driving the growth of the phenylketonuria therapeutic market and improving patient outcomes.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Phenylketonuria Therapeutic market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

Scope of Phenylketonuria Therapeutic Market Report

Report Metric Details
Report Name Phenylketonuria Therapeutic Market
Accounted market size in 2022 US$ 1000 million
Forecasted market size in 2029 US$ 1783.2 million
CAGR 8.6%
Base Year 2022
Forecasted years 2023 - 2029
Segment by Type
  • Medications
  • Supplements
Segment by Application
  • Household
  • Hospital
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives, Firstplay Dietary
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

FAQ for this report

How fast is Phenylketonuria Therapeutic Market growing?

Ans: The Phenylketonuria Therapeutic Market witnessing a CAGR of 8.6% during the forecast period 2023-2029.

What is the Phenylketonuria Therapeutic Market size in 2029?

Ans: The Phenylketonuria Therapeutic Market size in 2029 will be US$ 1783.2 million.

Who are the main players in the Phenylketonuria Therapeutic Market report?

Ans: The main players in the Phenylketonuria Therapeutic Market are Biomarin, Mead Johnson, Abbott, Nutricia, Dr. Schär, Vitaflo, Cambrooke, PKU Perspectives, Firstplay Dietary

What are the Application segmentation covered in the Phenylketonuria Therapeutic Market report?

Ans: The Applications covered in the Phenylketonuria Therapeutic Market report are Household, Hospital

What are the Type segmentation covered in the Phenylketonuria Therapeutic Market report?

Ans: The Types covered in the Phenylketonuria Therapeutic Market report are Medications, Supplements

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Phenylketonuria Therapeutic Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Medications
1.2.3 Supplements
1.3 Market by Application
1.3.1 Global Phenylketonuria Therapeutic Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Household
1.3.3 Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Phenylketonuria Therapeutic Market Perspective (2018-2029)
2.2 Phenylketonuria Therapeutic Growth Trends by Region
2.2.1 Global Phenylketonuria Therapeutic Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Phenylketonuria Therapeutic Historic Market Size by Region (2018-2023)
2.2.3 Phenylketonuria Therapeutic Forecasted Market Size by Region (2024-2029)
2.3 Phenylketonuria Therapeutic Market Dynamics
2.3.1 Phenylketonuria Therapeutic Industry Trends
2.3.2 Phenylketonuria Therapeutic Market Drivers
2.3.3 Phenylketonuria Therapeutic Market Challenges
2.3.4 Phenylketonuria Therapeutic Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Phenylketonuria Therapeutic Players by Revenue
3.1.1 Global Top Phenylketonuria Therapeutic Players by Revenue (2018-2023)
3.1.2 Global Phenylketonuria Therapeutic Revenue Market Share by Players (2018-2023)
3.2 Global Phenylketonuria Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Phenylketonuria Therapeutic Revenue
3.4 Global Phenylketonuria Therapeutic Market Concentration Ratio
3.4.1 Global Phenylketonuria Therapeutic Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Phenylketonuria Therapeutic Revenue in 2022
3.5 Phenylketonuria Therapeutic Key Players Head office and Area Served
3.6 Key Players Phenylketonuria Therapeutic Product Solution and Service
3.7 Date of Enter into Phenylketonuria Therapeutic Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Phenylketonuria Therapeutic Breakdown Data by Type
4.1 Global Phenylketonuria Therapeutic Historic Market Size by Type (2018-2023)
4.2 Global Phenylketonuria Therapeutic Forecasted Market Size by Type (2024-2029)
5 Phenylketonuria Therapeutic Breakdown Data by Application
5.1 Global Phenylketonuria Therapeutic Historic Market Size by Application (2018-2023)
5.2 Global Phenylketonuria Therapeutic Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Phenylketonuria Therapeutic Market Size (2018-2029)
6.2 North America Phenylketonuria Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Phenylketonuria Therapeutic Market Size by Country (2018-2023)
6.4 North America Phenylketonuria Therapeutic Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Phenylketonuria Therapeutic Market Size (2018-2029)
7.2 Europe Phenylketonuria Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Phenylketonuria Therapeutic Market Size by Country (2018-2023)
7.4 Europe Phenylketonuria Therapeutic Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Phenylketonuria Therapeutic Market Size (2018-2029)
8.2 Asia-Pacific Phenylketonuria Therapeutic Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Phenylketonuria Therapeutic Market Size by Region (2018-2023)
8.4 Asia-Pacific Phenylketonuria Therapeutic Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Phenylketonuria Therapeutic Market Size (2018-2029)
9.2 Latin America Phenylketonuria Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Phenylketonuria Therapeutic Market Size by Country (2018-2023)
9.4 Latin America Phenylketonuria Therapeutic Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Phenylketonuria Therapeutic Market Size (2018-2029)
10.2 Middle East & Africa Phenylketonuria Therapeutic Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Phenylketonuria Therapeutic Market Size by Country (2018-2023)
10.4 Middle East & Africa Phenylketonuria Therapeutic Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Biomarin
11.1.1 Biomarin Company Detail
11.1.2 Biomarin Business Overview
11.1.3 Biomarin Phenylketonuria Therapeutic Introduction
11.1.4 Biomarin Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.1.5 Biomarin Recent Development
11.2 Mead Johnson
11.2.1 Mead Johnson Company Detail
11.2.2 Mead Johnson Business Overview
11.2.3 Mead Johnson Phenylketonuria Therapeutic Introduction
11.2.4 Mead Johnson Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.2.5 Mead Johnson Recent Development
11.3 Abbott
11.3.1 Abbott Company Detail
11.3.2 Abbott Business Overview
11.3.3 Abbott Phenylketonuria Therapeutic Introduction
11.3.4 Abbott Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.3.5 Abbott Recent Development
11.4 Nutricia
11.4.1 Nutricia Company Detail
11.4.2 Nutricia Business Overview
11.4.3 Nutricia Phenylketonuria Therapeutic Introduction
11.4.4 Nutricia Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.4.5 Nutricia Recent Development
11.5 Dr. Schär
11.5.1 Dr. Schär Company Detail
11.5.2 Dr. Schär Business Overview
11.5.3 Dr. Schär Phenylketonuria Therapeutic Introduction
11.5.4 Dr. Schär Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.5.5 Dr. Schär Recent Development
11.6 Vitaflo
11.6.1 Vitaflo Company Detail
11.6.2 Vitaflo Business Overview
11.6.3 Vitaflo Phenylketonuria Therapeutic Introduction
11.6.4 Vitaflo Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.6.5 Vitaflo Recent Development
11.7 Cambrooke
11.7.1 Cambrooke Company Detail
11.7.2 Cambrooke Business Overview
11.7.3 Cambrooke Phenylketonuria Therapeutic Introduction
11.7.4 Cambrooke Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.7.5 Cambrooke Recent Development
11.8 PKU Perspectives
11.8.1 PKU Perspectives Company Detail
11.8.2 PKU Perspectives Business Overview
11.8.3 PKU Perspectives Phenylketonuria Therapeutic Introduction
11.8.4 PKU Perspectives Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.8.5 PKU Perspectives Recent Development
11.9 Firstplay Dietary
11.9.1 Firstplay Dietary Company Detail
11.9.2 Firstplay Dietary Business Overview
11.9.3 Firstplay Dietary Phenylketonuria Therapeutic Introduction
11.9.4 Firstplay Dietary Revenue in Phenylketonuria Therapeutic Business (2018-2023)
11.9.5 Firstplay Dietary Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Phenylketonuria Therapeutic Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Medications
    Table 3. Key Players of Supplements
    Table 4. Global Phenylketonuria Therapeutic Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 5. Global Phenylketonuria Therapeutic Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 6. Global Phenylketonuria Therapeutic Market Size by Region (2018-2023) & (US$ Million)
    Table 7. Global Phenylketonuria Therapeutic Market Share by Region (2018-2023)
    Table 8. Global Phenylketonuria Therapeutic Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 9. Global Phenylketonuria Therapeutic Market Share by Region (2024-2029)
    Table 10. Phenylketonuria Therapeutic Market Trends
    Table 11. Phenylketonuria Therapeutic Market Drivers
    Table 12. Phenylketonuria Therapeutic Market Challenges
    Table 13. Phenylketonuria Therapeutic Market Restraints
    Table 14. Global Phenylketonuria Therapeutic Revenue by Players (2018-2023) & (US$ Million)
    Table 15. Global Phenylketonuria Therapeutic Market Share by Players (2018-2023)
    Table 16. Global Top Phenylketonuria Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylketonuria Therapeutic as of 2022)
    Table 17. Ranking of Global Top Phenylketonuria Therapeutic Companies by Revenue (US$ Million) in 2022
    Table 18. Global 5 Largest Players Market Share by Phenylketonuria Therapeutic Revenue (CR5 and HHI) & (2018-2023)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Phenylketonuria Therapeutic Product Solution and Service
    Table 21. Date of Enter into Phenylketonuria Therapeutic Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Phenylketonuria Therapeutic Market Size by Type (2018-2023) & (US$ Million)
    Table 24. Global Phenylketonuria Therapeutic Revenue Market Share by Type (2018-2023)
    Table 25. Global Phenylketonuria Therapeutic Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 26. Global Phenylketonuria Therapeutic Revenue Market Share by Type (2024-2029)
    Table 27. Global Phenylketonuria Therapeutic Market Size by Application (2018-2023) & (US$ Million)
    Table 28. Global Phenylketonuria Therapeutic Revenue Market Share by Application (2018-2023)
    Table 29. Global Phenylketonuria Therapeutic Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 30. Global Phenylketonuria Therapeutic Revenue Market Share by Application (2024-2029)
    Table 31. North America Phenylketonuria Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 32. North America Phenylketonuria Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 33. North America Phenylketonuria Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 34. Europe Phenylketonuria Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. Europe Phenylketonuria Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 36. Europe Phenylketonuria Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Asia-Pacific Phenylketonuria Therapeutic Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Asia-Pacific Phenylketonuria Therapeutic Market Size by Region (2018-2023) & (US$ Million)
    Table 39. Asia-Pacific Phenylketonuria Therapeutic Market Size by Region (2024-2029) & (US$ Million)
    Table 40. Latin America Phenylketonuria Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Latin America Phenylketonuria Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 42. Latin America Phenylketonuria Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 43. Middle East & Africa Phenylketonuria Therapeutic Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Middle East & Africa Phenylketonuria Therapeutic Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Middle East & Africa Phenylketonuria Therapeutic Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Biomarin Company Detail
    Table 47. Biomarin Business Overview
    Table 48. Biomarin Phenylketonuria Therapeutic Product
    Table 49. Biomarin Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 50. Biomarin Recent Development
    Table 51. Mead Johnson Company Detail
    Table 52. Mead Johnson Business Overview
    Table 53. Mead Johnson Phenylketonuria Therapeutic Product
    Table 54. Mead Johnson Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 55. Mead Johnson Recent Development
    Table 56. Abbott Company Detail
    Table 57. Abbott Business Overview
    Table 58. Abbott Phenylketonuria Therapeutic Product
    Table 59. Abbott Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 60. Abbott Recent Development
    Table 61. Nutricia Company Detail
    Table 62. Nutricia Business Overview
    Table 63. Nutricia Phenylketonuria Therapeutic Product
    Table 64. Nutricia Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 65. Nutricia Recent Development
    Table 66. Dr. Schär Company Detail
    Table 67. Dr. Schär Business Overview
    Table 68. Dr. Schär Phenylketonuria Therapeutic Product
    Table 69. Dr. Schär Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 70. Dr. Schär Recent Development
    Table 71. Vitaflo Company Detail
    Table 72. Vitaflo Business Overview
    Table 73. Vitaflo Phenylketonuria Therapeutic Product
    Table 74. Vitaflo Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 75. Vitaflo Recent Development
    Table 76. Cambrooke Company Detail
    Table 77. Cambrooke Business Overview
    Table 78. Cambrooke Phenylketonuria Therapeutic Product
    Table 79. Cambrooke Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 80. Cambrooke Recent Development
    Table 81. PKU Perspectives Company Detail
    Table 82. PKU Perspectives Business Overview
    Table 83. PKU Perspectives Phenylketonuria Therapeutic Product
    Table 84. PKU Perspectives Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 85. PKU Perspectives Recent Development
    Table 86. Firstplay Dietary Company Detail
    Table 87. Firstplay Dietary Business Overview
    Table 88. Firstplay Dietary Phenylketonuria Therapeutic Product
    Table 89. Firstplay Dietary Revenue in Phenylketonuria Therapeutic Business (2018-2023) & (US$ Million)
    Table 90. Firstplay Dietary Recent Development
    Table 91. Research Programs/Design for This Report
    Table 92. Key Data Information from Secondary Sources
    Table 93. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Phenylketonuria Therapeutic Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Phenylketonuria Therapeutic Market Share by Type: 2022 VS 2029
    Figure 3. Medications Features
    Figure 4. Supplements Features
    Figure 5. Global Phenylketonuria Therapeutic Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 6. Global Phenylketonuria Therapeutic Market Share by Application: 2022 VS 2029
    Figure 7. Household Case Studies
    Figure 8. Hospital Case Studies
    Figure 9. Phenylketonuria Therapeutic Report Years Considered
    Figure 10. Global Phenylketonuria Therapeutic Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 11. Global Phenylketonuria Therapeutic Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 12. Global Phenylketonuria Therapeutic Market Share by Region: 2022 VS 2029
    Figure 13. Global Phenylketonuria Therapeutic Market Share by Players in 2022
    Figure 14. Global Top Phenylketonuria Therapeutic Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Phenylketonuria Therapeutic as of 2022)
    Figure 15. The Top 10 and 5 Players Market Share by Phenylketonuria Therapeutic Revenue in 2022
    Figure 16. North America Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 17. North America Phenylketonuria Therapeutic Market Share by Country (2018-2029)
    Figure 18. United States Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 19. Canada Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 20. Europe Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 21. Europe Phenylketonuria Therapeutic Market Share by Country (2018-2029)
    Figure 22. Germany Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 23. France Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. U.K. Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Italy Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Russia Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 27. Nordic Countries Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. Asia-Pacific Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. Asia-Pacific Phenylketonuria Therapeutic Market Share by Region (2018-2029)
    Figure 30. China Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Japan Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. South Korea Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Southeast Asia Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. India Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 35. Australia Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Latin America Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. Latin America Phenylketonuria Therapeutic Market Share by Country (2018-2029)
    Figure 38. Mexico Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. Brazil Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Middle East & Africa Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Middle East & Africa Phenylketonuria Therapeutic Market Share by Country (2018-2029)
    Figure 42. Turkey Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 43. Saudi Arabia Phenylketonuria Therapeutic Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Biomarin Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 45. Mead Johnson Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 46. Abbott Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 47. Nutricia Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 48. Dr. Schär Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 49. Vitaflo Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 50. Cambrooke Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 51. PKU Perspectives Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 52. Firstplay Dietary Revenue Growth Rate in Phenylketonuria Therapeutic Business (2018-2023)
    Figure 53. Bottom-up and Top-down Approaches for This Report
    Figure 54. Data Triangulation
    Figure 55. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

SIMILAR REPORTS

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

RELATED REPORTS

Global Klippel Trenaunay Syndrome Treatment Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20L1035
Mon Jul 08 00:00:00 UTC 2024

Add to Cart

Global Oculopharyngeal Muscular Dystrophy (OPMD) Drugs Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-20M15561
Tue Jun 18 00:00:00 UTC 2024

Add to Cart

Global Gene Therapy Cell Culture Medias Market Research Report 2024

120 Pages
Type: Report
Code: QYRE-Auto-12Y13676
Tue Jun 11 00:00:00 UTC 2024

Add to Cart

Myotonic Dystrophy Treatment - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

120 Pages
Type: Report
Code: QYRE-Auto-11F9960
Mon Jun 10 00:00:00 UTC 2024

Add to Cart